Persistent peritoneal dialysis catheter exit-site leak in a patient receiving maintenance immunosuppression with sirolimus

Clinical Transplantation

Volumn 22, Issue 5, 2008, Pages 672-673

  Perl, Jeffrey ^a   Jassal, Sarbjit Vanita ^a   Bargman, Joanne M ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b NONE   (Canada)

Author keywords

Dialysis after renal allograft loss; Failed renal allograft; Peritoneal dialysis; Peritoneal dialysis access; Sirolimus

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN;

ADULT; ARTICLE; CASE REPORT; CATHETER COMPLICATION; CHRONIC PYELONEPHRITIS; DIALYSIS CATHETER; DRUG DOSE REDUCTION; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LAPAROSCOPY; NEPHROTOXICITY; PERITONEAL CATHETER; PERITONEAL DIALYSIS; PRIORITY JOURNAL; REFLUX NEPHROPATHY; RENAL GRAFT DYSFUNCTION;

CATHETERS, INDWELLING; CONTINUITY OF PATIENT CARE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MIDDLE AGED; PERITONEAL DIALYSIS; SIROLIMUS;

EID: 52649098447     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2008.00823.x     Document Type: Article

References (4)

1. Jassal SV, Lok CE, Walele A, Bargman JM. Continued transplant immunosuppression may prolong survival after return to peritoneal dialysis: Results of a decision analysis. Am J Kidney Dis 2002: 40: 178.
2. Dean PG, Lund WJ, Larson TS et al. Wound-healing complications after kidney transplantation: A prospective, randomized comparison of sirolimus and tacrolimus. Transplantation 2004: 77: 1555.
3. Campistol JM, Eris J, Oberbauer R et al. Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation. J Am Soc Nephrol 2006: 17: 581.
4. Gill JS, Rose C, Pereira BJ, Tonelli M. The importance of transitions between dialysis and transplantation in the care of end-stage renal disease patients. Kidney Int 2007: 71: 442.